MarketCap
Facebook
X
TelegramOrphazyme A/S EBITDA per Share | ORPH
EBITDA per Share Jährlich Orphazyme A/S
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.432 | 0.645 | 0.103 | -0.0899 | 1.08 | 1.33 | 0.751 | 1.22 | - | 0.271 | 0.102 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.33 | -0.0899 | 0.584 |
EBITDA per Share anderer Aktien in der Pharmaeinzelhändler
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Brainstorm Cell Therapeutics
BCLI
|
-1.05 | - | -2.5 % | $ 5.88 M |  USA |
 |
BeiGene, Ltd.
BGNE
|
0.42 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
EyePoint Pharmaceuticals
EYPT
|
-3.29 K | $ 0.39 | 9.06 % | $ 28.6 K | USA |
 |
Bio-Path Holdings
BPTH
|
-4.97 | - | - | $ 100 K | USA |
 |
Cara Therapeutics
CARA
|
-3.59 | - | -3.03 % | $ 260 M | USA |
 |
ChromaDex Corporation
CDXC
|
0.21 | - | -0.88 % | $ 598 M | USA |
 |
Caladrius Biosciences
CLBS
|
-2.08 | - | -16.75 % | $ 25.8 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
-3.85 | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-3.85 | - | -4.36 % | $ 27 M | USA |
 |
Diffusion Pharmaceuticals
DFFN
|
-3.13 | - | 11.68 % | $ 8.97 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
-0.87 | - | -5.68 % | $ 8.28 M | USA |
 |
Enochian Biosciences
ENOB
|
-2.56 | - | - | $ 40.5 M | USA |
 |
Esperion Therapeutics
ESPR
|
0.29 | - | - | $ 661 M | USA |
 |
Evofem Biosciences
EVFM
|
0.03 | - | 7.55 % | $ 38.1 M | USA |
 |
Eyenovia
EYEN
|
-9.34 | - | 49.81 % | $ 13.2 M | USA |
 |
FibroGen
FGEN
|
-11.2 | - | - | $ 889 M | USA |
 |
Homology Medicines
FIXX
|
1.41 | - | 0.77 % | $ 53.4 M | USA |
 |
Amicus Therapeutics
FOLD
|
0.13 | - | - | $ 4.47 B | USA |
 |
Frequency Therapeutics
FREQ
|
-12.5 | - | - | $ 528 M | USA |
|
Galecto
GLTO
|
-155 | - | - | $ 762 M |  Danmark |
 |
GlycoMimetics
GLYC
|
-5.54 | - | 9357.83 % | $ 1.01 B | USA |
 |
Graybug Vision
GRAY
|
-1.54 | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
-0.03 | - | -32.59 % | $ 7.61 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
-0.82 | - | 1.35 % | $ 17.8 M |  China |
 |
Novavax
NVAX
|
2.97 | $ 10.15 | -6.8 % | $ 1.64 B | USA |
 |
Hepion Pharmaceuticals
HEPA
|
-0.44 | - | -18.79 % | $ 39.3 K | USA |
 |
Hoth Therapeutics
HOTH
|
-0.9 | - | - | $ 18.8 M | USA |
 |
IMARA
IMRA
|
-2.11 | - | 15.96 % | $ 663 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
-2.06 | - | - | $ 1.45 B |  Britain |
 |
KemPharm
KMPH
|
-1.06 | - | -0.34 % | $ 200 M | USA |
 |
Kezar Life Sciences
KZR
|
-7.96 | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
-0.58 | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
-4.6 | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
-1.45 | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
-7.75 | - | 0.43 % | $ 12 M | USA |
 |
OncoCyte Corporation
OCX
|
-1.61 | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
-2.17 | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
-0.13 | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
-2.45 | $ 8.74 | 0.52 % | $ 606 M | USA |
|
BiomX
PHGE
|
-23.6 | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
-3.43 | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
-0.19 | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
-2.51 | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
-5.48 | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
-0.1 | - | -6.08 % | $ 184 M | China |
 |
Cassava Sciences
SAVA
|
-1.96 | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
-5.43 | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
-0.42 | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
-130 | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
-17.6 | - | - | $ 17.5 M | USA |